Kornitzer Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-11,320
| Closed | -$376K | – | 474 |
|
|
2017
Q2 | $376K | Buy |
11,320
+1,870
| +20% | +$62.1K | 0.01% | 446 |
|
|
2017
Q1 | $303K | Sell |
9,450
-16,330
| -63% | -$524K | 0.01% | 445 |
|
|
2016
Q4 | $935K | Sell |
25,780
-33,700
| -57% | -$1.22M | 0.02% | 379 |
|
|
2016
Q3 | $2.74M | Sell |
59,480
-75
| -0.1% | -$3.45K | 0.05% | 287 |
|
|
2016
Q2 | $2.99M | Sell |
59,555
-68
| -0.1% | -$3.42K | 0.05% | 277 |
|
|
2016
Q1 | $3.19M | Sell |
59,623
-47,200
| -44% | -$2.53M | 0.05% | 272 |
|
|
2015
Q4 | $7.01M | Sell |
106,823
-10,882
| -9% | -$714K | 0.11% | 229 |
|
|
2015
Q3 | $6.65M | Sell |
117,705
-2,100
| -2% | -$119K | 0.11% | 235 |
|
|
2015
Q2 | $7.08M | Buy |
119,805
+50
| +0% | +$2.96K | 0.1% | 239 |
|
|
2015
Q1 | $7.46M | Buy |
119,755
+1,980
| +2% | +$123K | 0.09% | 226 |
|
|
2014
Q4 | $6.77M | Buy |
117,775
+2,050
| +2% | +$118K | 0.08% | 232 |
|
|
2014
Q3 | $6.22M | Buy |
115,725
+4,025
| +4% | +$216K | 0.07% | 236 |
|
|
2014
Q2 | $5.86M | Buy |
111,700
+8,300
| +8% | +$435K | 0.06% | 250 |
|
|
2014
Q1 | $5.46M | Buy |
103,400
+31,200
| +43% | +$1.65M | 0.06% | 261 |
|
|
2013
Q4 | $2.89M | Buy |
72,200
+56,495
| +360% | +$2.26M | 0.03% | 306 |
|
|
2013
Q3 | $593K | Hold |
15,705
| – | – | 0.01% | 361 |
|
|
2013
Q2 | $616K | Buy |
+15,705
| New | +$616K | 0.01% | 354 |
|